← Eichor
Condition: Polymyalgia Rheumatica Pmr Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Polymyalgia Rheumatica Pmr

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)
Phase N/A · 76 location(s) · University of Leeds · NCT04102930
Assessing Biomarker in Giant Cell Arteritis and Polymyalgia Rheumatic
Phase N/A · 1 location(s) · University of Bonn · NCT06460142
Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arterit
Phase N/A · 1 location(s) · University Hospital, Basel, Switzerland · NCT05479448
Rheumatology Patient Registry and Biorepository
Phase N/A · 1 location(s) · Yale University · NCT04402086
Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency
Phase 4 · 3 location(s) · Marianne Christina Klose · NCT05435781
Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia Rheumatica
Phase 3 · 1 location(s) · Zhejiang University · NCT06172361
A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoi
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT06647134
Giant Cell Arteritis - Ways to Precision Medicine
Phase N/A · 1 location(s) · Wuerzburg University Hospital · NCT07084480
DANIsh VASculitis Database (DANIVAS)
Phase N/A · 2 location(s) · Aarhus University Hospital · NCT05935709
Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica
Phase 4 · 14 location(s) · Sanofi · NCT07286214
Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
Phase N/A · 1 location(s) · University of Bonn · NCT07150000
Justification And Evaluation of Baricitinib Plus Corticosteroids Versus corticosteroiDs Alone in pOlymyalgia RhEumatica
Phase 3 · 22 location(s) · University Hospital, Brest · NCT07279688
AYLo - AutoimmunitY and Loss of y
Phase N/A · 1 location(s) · University of Bonn · NCT06696027
Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire Dijon · NCT06609668
Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatmen
Phase 4 · 3 location(s) · Marianne Andersen · NCT05193396
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Phase 2 · 1 location(s) · NYU Langone Health · NCT07138898
Using Novel Imaging to Rethink Diagnostic and Treatment Strategies for Polymyalgia Rheumatica
Phase N/A · 7 location(s) · Kresten Krarup Keller · NCT07010484
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.